"I Don’t Need The Money, & It’s A Pain-In-The...": Bryan Johnson To Exit Anti-Ageing Startup 'Blueprint'
Bryan Johnson, the 47-year-old tech entrepreneur best known for his ambitious anti-ageing experiment Project Blueprint, has revealed plans to either sell or shut down his startup, Blueprint, calling it a “pain-in-the-ass company.”
The candid admission came during a recent interview with Wired, on Tuesday, where Johnson, who has spent over ₹17 crore annually on his personal longevity protocol, said, “Honestly, I am so close to either shutting it down or selling it. I don’t need the money, and it’s a pain-in-the-ass company.” He added that he’s already in conversations with potential buyers.
The decision marks a striking pivot for Johnson, who recently launched a personal belief system he calls Don’t Die — a religion he announced on the social media platform X in March.
On @netflix Jan 1
2025 is the year of don’t die pic.twitter.com/RJosMclnJb
— Bryan Johnson (@bryan_johnson) December 11, 2024
As his philosophical and spiritual pursuits take centre stage, Johnson is increasingly distancing himself from the commercial side of his wellness empire.
Blueprint, which sells longevity-focused health products like a ₹4,700 “longevity mix” and a ₹3,600 mushroom coffee called Super Shrooms, was reportedly launched because Johnson’s friends sought access to the supplements he used. “It evolved in a way where I was trying to do people a solid,” he said.
Read also: Meet Dr. Gita Gopinath: The Esteemed Economist Returning To Harvard After Leading At The IMF
But he now believes the business detracts from his credibility as a thinker and spiritual guide: “People see the business and give me less credibility on the philosophy side… It is not worth it to me,” he added.
Earlier this year, The New York Times reported that Blueprint was facing serious financial stress, allegedly falling short of its break-even point by $1 million a month. Johnson, however, denies any financial emergency, telling Wired, “We are break-even… We’ve had profitable months, we’ve had loss months.”
Read also: Top Industrialist’s Warning On India’s 4th Largest Economy Feat
Despite Johnson’s public confidence, industry insiders speculate that maintaining a company at the bleeding edge of biohacking while also leading a philosophical movement may have proved unsustainable, even for someone as iconoclastic and driven as Johnson.
